Company PainReform Ltd.

PRFX

IL0011651580

Pharmaceuticals

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-10 pm EDT			5-day change	1st Jan Change
0.78 ^USD	-3.70%		-4.99%	-71.64%

Apr. 16	PainReform Prices $4 Million Offering; Shares Tumble Pre-Bell	MT
Apr. 09	Painreform Ltd. Announces Groundbreaking Results from New Studies Demonstrating the Superior In-Vitro Release Rates of PRF-110	CI

PAINREFORM LTD is a Israel-based pharmaceutical Company. The Companyâs main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

Number of employees: 7

Managers	Title	Age	Since
Ilan Hadar CEO	Chief Executive Officer	55	20-11-22
Ehud Geller CHM	Chairman	77	08-10-31
Sigal Aviel COO	Chief Operating Officer	60	-
Eli Hazum CTO	Chief Tech/Sci/R&D Officer	76	11-12-31
Rita Keynan PRN	Corporate Officer/Principal	-	21-01-05

Members of the board	Title	Age	Since
Augustine Lawlor BRD	Director/Board Member	67	20-08-31
Ellen Baron BRD	Director/Board Member	71	20-08-31
Ehud Geller CHM	Chairman	77	08-10-31
Eli Hazum CTO	Chief Tech/Sci/R&D Officer	76	11-12-31
Efi Cohen-Arazi BRD	Director/Board Member	51	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	2,473,743	1,926,327 ( 77.87 %)	0	77.87 %

Name	Equities	%	Valuation
Medica Venture Partners 19.05 %	329,228	19.05 %	599 195 $
Armistice Capital LLC 9.836 %	170,000	9.836 %	309 400 $
Intracoastal Capital LLC 6.457 %	111,600	6.457 %	203 112 $
XT Investments Ltd 6.167 %	106,588	6.167 %	193 990 $
Osaic Wealth, Inc. 0.2662 %	4,600	0.2662 %	8 372 $

PainReform Ltd.

65 Yigal Alon Street

6744316, Tel Aviv

http://www.painreform.com

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.78 USD

Average target price

11 USD

Spread / Average Target

+1,310.26%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
PAINREFORM LTD.	-71.64%	1.93M
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals